Hyperfine Appoints Roots Pharmaceutical as Distributor of Swoop Portable Brain MRI in Kuwait and UAE
Hyperfine has announced the appointment of Roots Pharmaceutical as its exclusive distribution partner for the Swoop system in Kuwait and the United Arab Emirates (UAE). Under the agreement, Roots Pharmaceutical will support market development, local regulatory activities, product education, demonstrations, customer engagement, and, following any applicable regulatory clearances, commercial and service activities for the Swoop system across both countries. The partnership represents an important step in Hyperfine’s international growth strategy and reflects its commitment to expanding access to brain imaging technologies globally.
The neurological conditions for which the Swoop system may be used, including stroke and neurodegenerative diseases, represent major global health challenges in which faster, decentralized access to MRI can make a meaningful difference. Kuwait and the UAE continue to invest significantly in healthcare infrastructure, digital transformation, and advanced diagnostic capabilities, creating strong opportunities for innovative technologies that improve patient access and clinical efficiency.
Eric Willis, Vice President of International at Hyperfine, said expanding into new countries is one of the growth vectors for the company’s international business. Willis noted that Hyperfine is excited to partner with Roots Pharmaceutical to support the introduction and drive future adoption of the Swoop system across these markets, and that Roots brings strong customer relationships and a deep understanding of the healthcare landscape throughout the Gulf Cooperation Council region.
Roots Pharmaceutical is a Kuwait-based healthcare company with extensive experience commercializing innovative healthcare technologies and specialty medical products across the GCC region, having built a reputation for successfully launching and supporting novel therapies and technologies in collaboration with global healthcare partners.
Islam Zayed, Chief Executive Officer of Roots Pharmaceutical, said the company is honored to be selected as Hyperfine’s distribution partner for Kuwait and the UAE. Zayed noted that the Swoop system represents a significant advancement in diagnostic brain imaging and aligns closely with the company’s mission of bringing innovative healthcare solutions to the region, and that this portable brain MRI technology can help hospitals improve access to critical diagnostic information while supporting better patient care across a variety of clinical settings. The appointment further strengthens Hyperfine’s global distribution network and supports its mission of making brain imaging more accessible worldwide.
